Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast

This publication has 14 references indexed in Scilit:

• Mutations inPlasmodium falciparumDihydrofolate Reductase and Dihydropteroate Synthase and Epidemiologic Patterns of Pyrimethamine‐Sulfadoxine Use and Resistance
  The Journal of Infectious Diseases, 1997
• Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria
  Antimicrobial Agents and Chemotherapy, 1997
• Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum
  Molecular and Biochemical Parasitology, 1997
• Community Pyrimethamine-Sulfadoxine Use and Prevalence of Resistant Plasmodium falciparum Genotypes in Mali: A Model for Deterring Resistance
  The American Journal of Tropical Medicine and Hygiene, 1996
• Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996
• Atovaquone and proguanil for Plasmodium falciparum malaria
  The Lancet, 1996
• Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
  Proceedings of the National Academy of Sciences, 1996
• Prevalence of the Dihydrofolate Reductase Asn-108 Mutation as the Basis for Pyrimethamine-Resistant Falciparum Malaria in the Brazilian Amazon
  The American Journal of Tropical Medicine and Hygiene, 1991
• Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
  Proceedings of the National Academy of Sciences, 1990
• Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
  Proceedings of the National Academy of Sciences, 1990